Study of Non-Invasive Pulsed Electromagnetic Field Therapy for Women with Interstitial CystitisBladder Pain Syndrome
Led by Wake Forest University Health Sciences · Updated on 2026-09-28
75
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the safety and effectiveness of low-frequency pulsed electromagnetic field PEMF therapy for female adults with Interstitial CystitisBladder Pain Syndrome ICBPS. ICBPS is a chronic condition characterized by bladder and pelvic pain with urinary urgency or frequency, greatly impacting quality of life. The study focuses on reducing pain and urinary symptoms in women with this condition, addressing challenges due to its complex and varied causes and symptoms.
Participants will use a PEMF device consisting of a full body mat and targeted pelvic pad at home. The treatment involves lying on the mat with the pelvic pad placed over the pelvic area for two 8-minute sessions daily over 4 weeks. The study includes three groups one receiving active PEMF therapy without maintenance, one using a sham device without maintenance, and one receiving active therapy with weekly maintenance sessions for 3 additional months. After treatment, participants complete electronic questionnaires at 4, 8, 12, and 16 weeks post-enrollment.
Throughout the study, participants will be assessed for pelvic pain changes using the Brief Pain Inventory and symptom changes using several patient-reported scales and voiding diaries at baseline and follow-up points. The study will monitor safety and collect data on urinary and pelvic symptoms over 4 months. Participants self-administer treatment at home and complete electronic questionnaires remotely, with the study lasting approximately 16 weeks for each participant.
CONDITIONS
Brief Title
Investigation of PEMF Therapy for Female Patients With IC/BPS
Research Team
S
Stephen J Walker, PhD
K
Kaylee A Ferrara, BS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor
How This Trial Compares With Other Options
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Active PEMF therapy
Sham PEMF therapy
Guideline-based standard multimodal therapy
What it is
Non‑invasive Pulsed Electromagnetic Field (PEMF) therapy delivered via full‑body mat and pelvic pad for 4 weeks, then maintenance schedule (1 week per month for 3 months)
Sham device matching appearance and accessories of PEMF but delivering no electromagnetic field for 4 weeks
Current guideline‑recommended multimodal non‑surgical management of IC/BPS including behavioral strategies, oral medications, bladder instillations, as first‑line options
Role in trial
Investigational therapeutic condition being evaluated for safety and efficacy
Placebo‑control condition to compare against active PEMF
Represents clinical care outside trial context for comparison, but not randomized in this trial
Primary use
Being evaluated to reduce pelvic pain and IC/BPS symptoms
Control procedure for comparison in the trial
Established multimodal management to relieve IC/BPS symptoms in routine care
How it is given or performed
Delivered via full‑body mat plus pelvic pad connected to control unit, activated individually over flat surface
Same device components without electromagnetic output, applied under same conditions
Varies by patient but typically includes self‑care, oral medications taken per provider prescription, and bladder instillations performed in clinic
Evidence status
Clinical efficacy under evaluation in this trial; not yet established
Control comparator; no therapeutic efficacy expected
Multimodal therapy supported by clinical guideline and used routinely for symptom control
Important limitations
Trial is ongoing; efficacy and safety results are not yet available
Provides only placebo comparison without real‑world standard care context by itself
Guideline‑based standard care varies by patient and may not match trial eligibility exactly
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years - 80Years
FEMALE
Eligibility Criteria
You may qualify if you...
Female adults aged 18 to 80 years
Previously established clinical diagnosis of Interstitial Cystitis/Bladder Pain Syndrome
Current numeric rating scale (NRS) score of 6 or higher
History of cystoscopy with hydrodistension and bladder capacity measurement under anesthesia
No cognitive deficits
You will not qualify if you...
History of bladder, ovarian, or vaginal cancer
History of urethral diverticulum
History of radiation cystitis
History of spinal cord injury or spina bifida
History of Parkinson's disease, multiple sclerosis, or stroke
Current pacemaker or metal prosthesis implantation
Active urinary tract infection
Body mass index (BMI) over 40
Residual urine volume greater than 100cc
Currently pregnant
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Treatment
Duration - 4 weeks
Participants self-administer pulsed electromagnetic field therapy or a sham device at home twice daily for 8 minutes over 4 weeks.
Daily home treatment sessions
Follow-up
Duration - 12 weeks
Participants complete electronic questionnaires on bladder pain and urinary symptoms at 4, 8, 12, and 16 weeks after enrollment to monitor changes over time.
Questionnaires at weeks 4, 8, 12, and 16
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
3
Similar Trials
Acupuncture Combined With Behavioral Changes to Treat Interstitial CystitisBladder Pain Syndrome in Adults
Evaluating Aerobic Exercise Training and Connective Tissue Massage with Patient Education for Women with Bladder Pain Syndrome
Evaluating Amniotic Membrane Therapy Using Clarix FLO for Women with Interstitial CystitisPainful Bladder Syndrome A Randomized, Double-Blind Controlled Trial
Comparing Single Dose Versus 3-Day Nitrofurantoin to Prevent Urinary Tract Infections
After Bladder Botox Injections for Overactive Bladder or Bladder Pain Syndrome
Randomized Study Comparing Electroacupuncture and Amitriptyline for Treating Bladder Pain Syndrome with Brain Activity Analysis
Study Comparing Bladder Botox Injection Versus Lifestyle Changes
on Sexual Function in Women with Bladder Pain Syndrome
Evaluating a Brief Cognitive Behavioral Therapy vs Education for Urologic Chronic Pelvic Pain Syndrome with Focus on Treatment Processes and Outcomes
Study of Catheter-Free Intravesical Instillation Using a Special Syringe Adapter for Bladder Conditions in Adults Aged 18 to 80
Study of Brain fMRI Findings and Symptoms in Women Aged 18 and Older With Bladder Pain Syndrome
Genetic Investigation of Chronic Prostatitis and Chronic Pelvic Pain Syndrome Including Related Bladder Conditions in Families in the USA and Canada
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The role of a leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis/overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic pain.